155 related articles for article (PubMed ID: 22058216)
1. A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.
Janiszewska H; Bak A; Pilarska M; Heise M; Junkiert-Czarnecka A; Kuliszkiewicz-Janus M; Całbecka M; Jaźwiec B; Wołowiec D; Kuliczkowski K; Haus O
Haematologica; 2012 Mar; 97(3):366-70. PubMed ID: 22058216
[TBL] [Abstract][Full Text] [Related]
2. CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Bayram S; Topaktaş M; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2012 Oct; 36(5):453-7. PubMed ID: 22521562
[TBL] [Abstract][Full Text] [Related]
3. Association of two mutations in the CHEK2 gene with breast cancer.
Bogdanova N; Enssen-Dubrowinskaja N; Feshchenko S; Lazjuk GI; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Dörk T
Int J Cancer; 2005 Aug; 116(2):263-6. PubMed ID: 15810020
[TBL] [Abstract][Full Text] [Related]
4. A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.
Bąk A; Janiszewska H; Junkiert-Czarnecka A; Heise M; Pilarska-Deltow M; Laskowski R; Pasińska M; Haus O
Hered Cancer Clin Pract; 2014 Apr; 12(1):10. PubMed ID: 24713400
[TBL] [Abstract][Full Text] [Related]
5. CHEK2 mutations and the risk of papillary thyroid cancer.
Siołek M; Cybulski C; Gąsior-Perczak D; Kowalik A; Kozak-Klonowska B; Kowalska A; Chłopek M; Kluźniak W; Wokołorczyk D; Pałyga I; Walczyk A; Lizis-Kolus K; Sun P; Lubiński J; Narod SA; Góźdż S
Int J Cancer; 2015 Aug; 137(3):548-52. PubMed ID: 25583358
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.
Kaufman B; Laitman Y; Gronwald J; Winqvist R; Irmejs A; Lubinski J; Pylkäs K; Gardovskis J; Miklasevics E; Friedman E
Fam Cancer; 2009; 8(4):473-8. PubMed ID: 19609724
[TBL] [Abstract][Full Text] [Related]
7. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W
Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
[TBL] [Abstract][Full Text] [Related]
8. Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.
Myszka A; Karpinski P; Slezak R; Czemarmazowicz H; Stembalska A; Gil J; Laczmanska I; Bednarczyk D; Szmida E; Sasiadek MM
J Appl Genet; 2011 May; 52(2):185-91. PubMed ID: 21120647
[TBL] [Abstract][Full Text] [Related]
9. The risk of gastric cancer in carriers of CHEK2 mutations.
Teodorczyk U; Cybulski C; Wokołorczyk D; Jakubowska A; Starzyńska T; Lawniczak M; Domagała P; Ferenc K; Marlicz K; Banaszkiewicz Z; Wiśniowski R; Narod SA; Lubiński J
Fam Cancer; 2013 Sep; 12(3):473-8. PubMed ID: 23296741
[TBL] [Abstract][Full Text] [Related]
10. A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cybulski C; Huzarski T; Górski B; Masojć B; Mierzejewski M; Debniak T; Gliniewicz B; Matyjasik J; Złowocka E; Kurzawski G; Sikorski A; Posmyk M; Szwiec M; Czajka R; Narod SA; Lubiński J
Cancer Res; 2004 Apr; 64(8):2677-9. PubMed ID: 15087378
[TBL] [Abstract][Full Text] [Related]
11. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
van Puijenbroek M; van Asperen CJ; van Mil A; Devilee P; van Wezel T; Morreau H
J Pathol; 2005 Jun; 206(2):198-204. PubMed ID: 15818573
[TBL] [Abstract][Full Text] [Related]
12. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
13. Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.
Janiszewska H; Bąk A; Skonieczka K; Jaśkowiec A; Kiełbiński M; Jachalska A; Czyżewska M; Jaźwiec B; Kuliszkiewicz-Janus M; Czyż J; Kuliczkowski K; Haus O
Leuk Res; 2018 Jul; 70():74-78. PubMed ID: 29902706
[TBL] [Abstract][Full Text] [Related]
14. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Zdrojowy R; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Narod SA; Lubiński J
J Med Genet; 2006 Nov; 43(11):863-6. PubMed ID: 17085682
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
[TBL] [Abstract][Full Text] [Related]
16. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
17. Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma.
Havranek O; Spacek M; Hubacek P; Mocikova H; Markova J; Trneny M; Kleibl Z
Neoplasma; 2011; 58(5):392-5. PubMed ID: 21744992
[TBL] [Abstract][Full Text] [Related]
18. CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
[TBL] [Abstract][Full Text] [Related]
19. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J
Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448
[TBL] [Abstract][Full Text] [Related]
20. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cybulski C; Wokołorczyk D; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Masojć B; Deebniak T; Górski B; Blecharz P; Narod SA; Lubiński J
J Clin Oncol; 2011 Oct; 29(28):3747-52. PubMed ID: 21876083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
